Details for New Drug Application (NDA): 040029
✉ Email this page to a colleague
NDA 040029 describes KIONEX, which is a drug marketed by Ani Pharms and is included in two NDAs. It is available from one supplier. Additional details are available on the KIONEX profile page.
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
The generic ingredient in KIONEX is sodium polystyrene sulfonate. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the sodium polystyrene sulfonate profile page.
Summary for 040029
| Tradename: | KIONEX |
| Applicant: | Ani Pharms |
| Ingredient: | sodium polystyrene sulfonate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL, RECTAL | Strength | 454GM/BOT | ||||
| Approval Date: | Feb 6, 1998 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
